We are devoted to strengthening emerging pharmaceutical markets. To this end, we commit to upholding essential principles in all of our dealings with clients. Our Client Charter is our promise to you that ...
Our Quality Edge is how we blend Empathy, Reliability and Responsiveness to deliver exceptional service to all our clients.
We Partner with Clients to execute Outcomes Research in emerging markets.
We develop results-driven market access solutions for clients in emerging markets.
Market Access Solutions
Innovative Access Strategies
Our Quality Edge
NHI is no public health panacea. phrmaccess.com/x/lp pic.twitter.com/e0J9M4RYHh
About 2 days ago from Carapinha & Company's Twitter
Government granted ‘new powers’ to control generic medicine costs. phrmaccess.com/x/lr pic.twitter.com/O0H98RiLIz
Medical cannabis and the challenge for regulation of medicines. phrmaccess.com/x/le
About 4 days ago from Carapinha & Company's Twitter
Piecing Together the Pricing Puzzle: The Midterm Elections. phrmaccess.com/x/lf
Get your message out to an international audience. Shout Out Campaign. carapinha.com/contact-us-2/
Mylan’s first FDA-approved biosimilar drug to become available soon. phrmaccess.com/x/li pic.twitter.com/KkAK1foWD9
Roche & Saed Charity hold awareness workshop about multiple sclerosis disease. phrmaccess.com/x/l8 pic.twitter.com/9YIIffsKPH
About 5 days ago from Carapinha & Company's Twitter
Market Access Landscape in the Middle East. phrmaccess.com/x/la pic.twitter.com/9Ew6zEhcQ8
About 6 days ago from Carapinha & Company's Twitter
Only five out of 696 hospitals‚ clinics got a ‘pass mark’ in SA. phrmaccess.com/x/lc pic.twitter.com/xZetflCeMz
Co-Pay Tactic by Benefit Managers Credited with Cutting Prescription Drug Prices. phrmaccess.com/x/l3 pic.twitter.com/pJbN35VeQo
About a week ago from Carapinha & Company's Twitter
Shhh! Many Pharmacists Are Legally Banned From Telling Patients This. phrmaccess.com/x/l6 pic.twitter.com/78dOKPwSVh
RPT-U.S. FDA wants to shorten new drug monopolies to cut costs. phrmaccess.com/x/kz pic.twitter.com/Z5JUOQFt3D
About 2 weeks ago from Carapinha & Company's Twitter
Big pharma CEO: Congress is not solution oriented. phrmaccess.com/x/l0 pic.twitter.com/azPwscOatN
Gap in regulating biotech drug copies prompts WHO to step in. phrmaccess.com/x/kh pic.twitter.com/EM0fVQiUcx
European Commission Aims to Boost Generic, Biosimilar Manufacturing. phrmaccess.com/x/ke pic.twitter.com/Ift8MW5bb9
About 3 weeks ago from Carapinha & Company's Twitter